share_log

ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-INCON Co., Ltd.(3.44%)

SEC announcement ·  Jan 19 00:00
Summary by Moomoo AI
INCON Co., Ltd., a company based in the Republic of Korea, has filed an exit filing with the United States Securities and Exchange Commission (SEC) indicating that it has ceased to be the beneficial owner of more than five percent of ZyVersa Therapeutics, Inc.'s common stock. The filing, dated December 31, 2023, and submitted on January 17, 2024, shows that INCON Co., Ltd. now owns 42,777 shares, representing 3.44% of the class. This Schedule 13G/A amendment marks the change in ownership status for INCON Co., Ltd. with respect to ZyVersa Therapeutics, a company with principal executive offices in Weston, Florida.
INCON Co., Ltd., a company based in the Republic of Korea, has filed an exit filing with the United States Securities and Exchange Commission (SEC) indicating that it has ceased to be the beneficial owner of more than five percent of ZyVersa Therapeutics, Inc.'s common stock. The filing, dated December 31, 2023, and submitted on January 17, 2024, shows that INCON Co., Ltd. now owns 42,777 shares, representing 3.44% of the class. This Schedule 13G/A amendment marks the change in ownership status for INCON Co., Ltd. with respect to ZyVersa Therapeutics, a company with principal executive offices in Weston, Florida.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more